Jonathan Simon Fain, MD | |
335 Glessner Ave, Pathology Department, Mansfield, OH 44903-2269 | |
(419) 526-8509 | |
(419) 520-2846 |
Full Name | Jonathan Simon Fain |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 335 Glessner Ave, Mansfield, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790837615 | NPI | - | NPPES |
0881149 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35063392 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jonathan Simon Fain, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Jonathan Simon Fain, MD 335 Glessner Ave, Pathology Department, Mansfield, OH 44903-2269 Ph: (419) 526-8509 |
News Archive
In the health agency's report, there were 49,029 diagnoses made in 2018, which is about 8,000 more than the previous year, surpassing breast cancer with 47,476 cases. Lung cancer followed with 38,996 cases. The new data reveals that there were more cancers detected in 2018 in men than in women, with a total of 15,228 cases and 151,452, respectively.
Like a circuit breaker that prevents electrical wiring from overheating and bringing down the house, a tiny family of three molecules stops the immune system from mounting an out-of-control, destructive inflammatory response against invading pathogens, researchers at the Salk Institute for Biological Studies have found.
Cholangiocarcinoma is a malignant tumor, characterized by a poor prognosis and unresponsive to conventional chemotherapeutic agents. Therefore, searching for novel and effective therapeutic agents for CCA is necessary. In previous studies, several caged xanthones from G. hanburyi have been reported to be potent antiproliferatives as well as having anticancer and anti-tumor activities and they induce apoptosis in various cancer cell lines.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of SilenorĀ® (doxepin) 3 mg and 6 mg was submitted on September 16, 2010.
› Verified 8 days ago
Dr. Ian Craig Talbott, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave # 1370, Mansfield, OH 44903 Phone: 419-526-8486 | |
John Howard Burgess, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8000 Fax: 418-520-2846 | |
Dr. Karen Sue Wagenhals, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8486 | |
Dr. Homer O Wiland Iv, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 330-718-1740 |